Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

• Wolfe Research Healthcare Conference on Tuesday, November 10 at 11:20 AM Eastern Time
• UBS Global Biopharma Conference on Tuesday, November 17 at 10:00 AM Greenwich Mean Time
• Jefferies Global Healthcare Conference on Tuesday, November 17 at 2:30 PM Greenwich Mean Time
• Citi’s Global Healthcare Conference on Tuesday, December 1 at 11:00 AM Eastern Time
• Annual Evercore Healthcare Conference on Wednesday, December 2 at 11:40 AM Eastern Time

The live webcasts can be accessed on the company’s investor relations website at investors.gilead.com. The replays will be available for at least 30 days following each presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261030499668/en/